CSIMarket
 
Gelesis Holdings Inc   (GLS)
Other Ticker:  
 
 
Price: $0.1586 $0.00 0.380%
Day's High: $0.1622 Week Perf: -3.35 %
Day's Low: $ 0.15 30 Day Perf: -31.16 %
Volume (M): 185 52 Wk High: $ 0.29
Volume (M$): $ 29 52 Wk Avg: $0.17
Open: $0.15 52 Wk Low: $0.13



 Market Capitalization (Millions $) 12
 Shares Outstanding (Millions) 73
 Employees -
 Revenues (TTM) (Millions $) 12
 Net Income (TTM) (Millions $) -53
 Cash Flow (TTM) (Millions $) -17
 Capital Exp. (TTM) (Millions $) 4

Gelesis Holdings Inc
Gelesis Holdings Inc is a biotechnology company focused on developing and commercializing treatments for obesity and gastrointestinal disorders. The company's flagship product, Plenity, is an oral, non-systemic capsule designed to induce a feeling of fullness and promote weight loss. Plenity is made up of naturally derived materials that expand in the stomach to help control appetite and reduce calorie intake. Gelesis Holdings Inc is committed to providing innovative and effective solutions for the management of obesity and related health conditions.


   Company Address: 501 Boylston Street Boston 2116 MA
   Company Phone Number: 456-4718   Stock Exchange / Ticker: GLS
   GLS is expected to report next financial results on March 27, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Gelesis Holdings Inc

Gelesis Holdings Inc Faces Severe Financial Challenges with Declining Revenue and Mounting Losses in Most Recent Fiscal Period

Gelesis Holdings Inc's Financial Report Reveals Declining Revenue and Surging Losses
Gelesis Holdings Inc, a major pharmaceutical preparations company, recently released its financial report for the April to June 30, 2023 time-frame. The report showcases some concerning figures, including a significant decrease in revenue and a surge in losses compared to the previous year.
In terms of earnings per share, Gelesis Holdings Inc reported a loss of $-0.10 per share, a slight improvement from the $-0.17 loss per share recorded in the same period last year. However, when compared to the previous reporting period, the company experienced a surge in losses, with earnings per share falling from $-0.07.

Gelesis Holdings Inc

Gelesis Holdings Inc Turns Losses into Profits, Paving the Way for a Bright Future

Gelesis Holdings Inc: A Bullish Outlook for the Future
Despite the challenging past couple of years for Gelesis Holdings Inc., the latest financial reports highlight a promising future for this fast-growing company. The financial time-frame ending March 31, 2023, brought good news for Gelesis Holdings Inc., as they were able to significantly reduce their loss per share from $-0.70 in the previous year to $-0.07 per share. This is an impressive increase that shows the company is making great strides towards profitability.
What's more, the EPS also improved, jumping from $-0.21 per share from the preceding reporting season to a more promising figure. These results are a testament to Gelesis Holdings Inc.'s commitment to financial excellence and suggest that the company is on the right path toward continued success.






 

Gelesis Holdings Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com